Developmental Myosin Heavy Chain Regulation and Function

发育性肌球蛋白重链调节和功能

基本信息

  • 批准号:
    6732009
  • 负责人:
  • 金额:
    $ 23.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The function of skeletal muscle is to produce the contractile force necessary for movement. One of the key proteins involved in muscle contraction is myosin, a hexamer consisting of two heavy chains and four light chains. Myosin heavy chain (MyHC) contains the motor domain and the rod domain necessary for thick filament formation. There are 8 known isoforms of MyHC expressed in striated muscle, 2 developmental and 6 adult. While the function and expression of the adult isoforms has been extensively characterized, relatively little is known about the role of the embryonic and perinatal skeletal muscle isoforms or of the factors regulating their expression. Their expression is initiated at mid-gestation, reaches a peak around birth, and is rapidly down regulated during early postnatal growth as they are replaced by the adult MyHC isoforms. During the prenatal period, muscle contraction but no coordinated movement occurs. Thus the exact function of these isoforms is poorly defined. We propose to evaluate the regulation and function of the two developmental MyHC isoforms using molecular and genetic approaches. First, we propose to study the cis- and trans-regulatory factors governing embryonic and perinatal MyHC expression by functionally analyzing the upstream regulatory regions of both genes. Promoter activities will be tested in cell culture and in mice; in the latter, both plasmid DNA injection and transient transgenics will be used to identify elements necessary for regulating the magnitude and pattern of expression during muscle development. Second, we will use homologous recombination to create mice in which either the embryonic or perinatal MyHC gene has been rendered null and study the resulting phenotype. Finally, to determine the role of the motor domain of embryonic MyHC in muscle development, we will create transgenic mice harboring a dominant mutation in the ATP binding domain. Specifically, we will test the hypothesis that embryonic MyHC contractile function is necessary for muscle development. These studies will define the role of the developmental MyHC isoforms in skeletal muscle form and function.
描述(由申请人提供):骨骼肌的功能是 产生运动所需的收缩力。一种关键的蛋白质 参与肌肉收缩的是肌球蛋白,一种由两个重链组成的六聚体, 四条轻链。肌球蛋白重链(MyHC)包含马达 域和杆域所必需的粗丝形成。有8 已知的MyHC亚型在横纹肌中表达,2发育和6 成年人了虽然成体同种型的功能和表达已经被研究, 广泛的特点,相对较少的是知道的作用, 胚胎和围产期骨骼肌亚型或调节因子 他们的表情。它们的表达起始于妊娠中期, 在出生前后达到高峰,在出生后早期生长期间迅速下调 因为它们被成人MyHC亚型取代。在产前期间, 肌肉收缩,但没有协调的运动发生。因此, 这些异构体的定义不明确。我们建议评估该条例, 利用分子和遗传学方法研究两种发育中MyHC亚型的功能 接近。首先,我们建议研究顺式和反式调节因子, 调控胚胎和围产期MyHC的表达, 两个基因的上游调控区。将测试促销活动 在细胞培养物和小鼠中;在后者中,质粒DNA注射和 瞬时转基因将用于确定必要的元素, 调节肌肉发育过程中表达的幅度和模式。 第二,我们将使用同源重组来创建小鼠,在小鼠中, 胚胎或围产期MyHC基因已呈现无效,并研究结果 表型最后,为了确定胚胎MyHC运动域的作用, 在肌肉发育方面,我们将创造出一种转基因小鼠, ATP结合域的突变。具体来说,我们将测试假设 胚胎MyHC收缩功能是肌肉发育所必需的。 这些研究将确定发育中MyHC亚型在 骨骼肌形态和功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leslie Anne Leinwand其他文献

Leslie Anne Leinwand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leslie Anne Leinwand', 18)}}的其他基金

Translating Python Biology to the Mammalian Heart
将Python生物学转化为哺乳动物心脏
  • 批准号:
    8704090
  • 财政年份:
    2014
  • 资助金额:
    $ 23.85万
  • 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
  • 批准号:
    8584984
  • 财政年份:
    2013
  • 资助金额:
    $ 23.85万
  • 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
  • 批准号:
    9058602
  • 财政年份:
    2013
  • 资助金额:
    $ 23.85万
  • 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
  • 批准号:
    8723276
  • 财政年份:
    2013
  • 资助金额:
    $ 23.85万
  • 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
  • 批准号:
    8843945
  • 财政年份:
    2013
  • 资助金额:
    $ 23.85万
  • 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
  • 批准号:
    7260196
  • 财政年份:
    2007
  • 资助金额:
    $ 23.85万
  • 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
  • 批准号:
    7406843
  • 财政年份:
    2007
  • 资助金额:
    $ 23.85万
  • 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
  • 批准号:
    7587246
  • 财政年份:
    2007
  • 资助金额:
    $ 23.85万
  • 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
  • 批准号:
    7789632
  • 财政年份:
    2007
  • 资助金额:
    $ 23.85万
  • 项目类别:
DENVER CARDIOVASCULAR HEALTH EDUCATION ALLIANCE, PHASE I
丹佛心血管健康教育联盟,第一阶段
  • 批准号:
    6663838
  • 财政年份:
    2002
  • 资助金额:
    $ 23.85万
  • 项目类别:

相似海外基金

CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
  • 批准号:
    2339849
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
  • 批准号:
    2336469
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
  • 批准号:
    2338573
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
  • 批准号:
    2330628
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
  • 批准号:
    BB/Y008898/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
  • 批准号:
    DP240102119
  • 财政年份:
    2024
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Discovery Projects
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    491942
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
  • 批准号:
    489704
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    494272
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了